Bingham Private Wealth LLC cut its position in Procter & Gamble Company (The) (NYSE:PG – Free Report) by 6.7% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,025 shares of the company’s stock after selling 146 shares during the period. Bingham Private Wealth LLC’s holdings in Procter & Gamble were worth $323,000 at the end of the most recent reporting period.
A number of other hedge funds have also added to or reduced their stakes in PG. Brighton Jones LLC boosted its stake in Procter & Gamble by 51.5% during the 4th quarter. Brighton Jones LLC now owns 40,068 shares of the company’s stock valued at $6,717,000 after purchasing an additional 13,617 shares during the last quarter. Taylor Financial Group Inc. boosted its stake in Procter & Gamble by 10.6% during the 1st quarter. Taylor Financial Group Inc. now owns 2,891 shares of the company’s stock valued at $493,000 after purchasing an additional 277 shares during the last quarter. Patriot Financial Group Insurance Agency LLC boosted its stake in shares of Procter & Gamble by 3.7% in the 1st quarter. Patriot Financial Group Insurance Agency LLC now owns 7,734 shares of the company’s stock worth $1,263,000 after buying an additional 275 shares during the last quarter. RDA Financial Network boosted its stake in shares of Procter & Gamble by 12.8% in the 1st quarter. RDA Financial Network now owns 1,865 shares of the company’s stock worth $318,000 after buying an additional 211 shares during the last quarter. Finally, Wedge Capital Management L L P NC boosted its stake in shares of Procter & Gamble by 2.9% in the 1st quarter. Wedge Capital Management L L P NC now owns 4,138 shares of the company’s stock worth $705,000 after buying an additional 116 shares during the last quarter. Institutional investors and hedge funds own 65.77% of the company’s stock.
Procter & Gamble Trading Down 1.2%
NYSE:PG opened at $150.47 on Tuesday. The company has a current ratio of 0.70, a quick ratio of 0.49 and a debt-to-equity ratio of 0.49. The stock has a market capitalization of $352.17 billion, a PE ratio of 23.11, a price-to-earnings-growth ratio of 4.02 and a beta of 0.36. The firm’s 50 day moving average is $155.38 and its 200 day moving average is $159.84. Procter & Gamble Company has a 12 month low of $149.91 and a 12 month high of $180.43.
Insider Buying and Selling at Procter & Gamble
In other Procter & Gamble news, insider Balaji Purushothaman sold 490 shares of the business’s stock in a transaction on Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total transaction of $74,592.70. Following the sale, the insider owned 12,616 shares of the company’s stock, valued at $1,920,533.68. The trade was a 3.74% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Jennifer L. Davis sold 3,227 shares of the business’s stock in a transaction on Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total transaction of $491,246.21. Following the sale, the chief executive officer directly owned 61,764 shares in the company, valued at $9,402,333.72. The trade was a 4.97% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 149,763 shares of company stock worth $23,421,279. Company insiders own 0.20% of the company’s stock.
Analyst Ratings Changes
A number of equities analysts have recently weighed in on the company. Wells Fargo & Company cut their target price on Procter & Gamble from $173.00 to $170.00 and set an “overweight” rating on the stock in a research note on Thursday, September 25th. UBS Group set a $180.00 target price on Procter & Gamble and gave the stock a “buy” rating in a research note on Wednesday, July 30th. BNP Paribas restated an “outperform” rating and issued a $177.00 target price on shares of Procter & Gamble in a research note on Friday, August 15th. BNP Paribas Exane cut their target price on Procter & Gamble from $177.00 to $172.00 and set an “outperform” rating on the stock in a research note on Tuesday, September 23rd. Finally, JPMorgan Chase & Co. restated a “neutral” rating and issued a $170.00 target price (down previously from $178.00) on shares of Procter & Gamble in a research note on Friday, July 25th. Eleven investment analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $173.11.
View Our Latest Stock Analysis on PG
Procter & Gamble Profile
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Featured Articles
- Five stocks we like better than Procter & Gamble
- Following Congress Stock Trades
- Eli Lilly Stock Soars on Trump Tariff Hopes and Pfizer Deal
- Stock Dividend Cuts Happen Are You Ready?
- 3 Exceptional Stocks to Build Long-Term Wealth
- What is a SEC Filing?
- Insider Sales Jump at Broadcom and CoreWeave: Red Flag Ahead?
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.